SEBI grants one-time extension for IPO approvals amid weak market conditions

SEBI eases intraday borrowing norms for mutual funds to manage liquidity mismatches

The Securities and Exchange Board of India (SEBI) has relaxed the framework governing intraday borrowings by mutual funds, permitting asset management companies (AMCs) to use short-term borrowings to manage liquidity mismatches arising during the trading day. The decision was approved at SEBI’s board meeting on Friday, June 19, chaired by SEBI Chairman Tuhin Kanta Pandey….

Read More
SEBI revises ETF framework to improve price discovery — key details here

SEBI chief signals push to ease barriers on long-term derivative contracts

Securities and Exchange Board of India (SEBI) Chairman Tuhin Kanta Pandey on Friday said the regulator would need to hold consultations with market participants to address concerns around longer-term derivative contracts, and was looking at ways to remove the barriers that currently limit such products. “All products, longer and shorter-term derivatives, should be available in…

Read More
SEBI revises ETF framework to improve price discovery — key details here

Mohandas Pai backs SEBI’s buyback revival, says battered markets are ideal for creating shareholder value

Mohandas Pai, Chairman of Aarin Capital and former CFO and board member at Infosys, has welcomed SEBI’s decision to revive open-market share buybacks, saying periods of market weakness offer companies an opportunity to create shareholder value and deploy excess cash more efficiently. Speaking to CNBC-TV18, Pai said the return of the mechanism restores an important…

Read More
TCS reacts to Nashik sexual harassment probe, says employees being investigated and suspended

TCS valuation slips to Wipro levels amid IT sector rout

Tata Consultancy Services (TCS), India’s largest IT services company, is steadily losing its valuation premium over peers in the sector. A recent sell-off, triggered by a weaker-than-expected fourth-quarter outlook from global rival Accenture, has dragged its valuation multiples lower. According to Bloomberg data, TCS currently trades at 13.5 times one-year forward earnings, almost on par…

Read More
Aurobindo arm CuraTeQ reports positive Phase 3 results for allergy drug BP11

Aurobindo Pharma subsidiary Eugia Steriles faces five US FDA observations

Drug maker Aurobindo Pharma Ltd on Friday (June 19) said the United States Food and Drug Administration (US FDA) has completed a pre-approval inspection (PAI) at Eugia Steriles Private Ltd with five observations. The inspection was conducted at Eugia Steriles’ manufacturing facility located in Parawada Mandal, Anakapalli District, Andhra Pradesh, from June 10, 2026, to…

Read More